Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbCellera Biologics Inc. - Common Shares
(NQ:
ABCL
)
4.570
-0.200 (-4.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbCellera Biologics Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer
September 10, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575
August 27, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
August 18, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
August 07, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
May 08, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
Via
Benzinga
AbCellera to Participate at Upcoming Investor Conferences in September
August 12, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
Expert Outlook: AbCellera Biologics Through The Eyes Of 4 Analysts
August 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 08, 2025
Via
Benzinga
AbCellera Biologics (ABCL) Q2 2025 Earnings Call Transcript
August 08, 2025
Via
The Motley Fool
Topics
Earnings
Curious about the stocks that are showing activity after the closing bell on Thursday?
August 07, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms
August 07, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday
July 21, 2025
Via
Benzinga
AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025
July 07, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
Why AbCellera Biologics Stock Raced Nearly 6% Higher Today
June 02, 2025
Via
The Motley Fool
AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575
May 30, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
May 14, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera’s Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit
May 12, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting
May 09, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Reports Q1 2025 Business Results
May 08, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025
April 29, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Participate at Upcoming Investor Conferences in May and June
April 08, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025
April 03, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025
March 25, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript
February 27, 2025
ABCL earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
AbCellera Reports Full Year 2024 Business Results
February 27, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Participate at Upcoming Investor Conferences in March
February 11, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Report Full Year 2024 Financial Results on February 27, 2025
January 21, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
January 13, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present at Upcoming Investor Conferences in December and January
November 21, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.